Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
Presse Medicale (Paris, France : 1983)
|
February 16, 2010
[Elderly people, precariousness, social handicap and length of stay: pilot study at the Lariboisière-Fernand Widal Hospital Group in Paris]
Nathalie Bréchat, Magali Besnier, Thomas Vogel, et al.
Pediatric Blood & Cancer
|
May 26, 2006
Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab?
Natacha Entz-Werle, Valérie Velasco, Agnès Neuville, et al.
Cancer Investigation
|
January 19, 2019
Clinical Response to Induction Chemotherapy Predicts Outcome after Combined-Modality Therapy in Inflammatory Breast Cancer
Mauro Loi, Ariane Dunant, Sahar Ghith, et al.
Cancers
|
October 28, 2023
Real-World Diagnostic Accuracy of the On-Site Cytopathology Advance Report (OSCAR) Procedure Performed in a Multidisciplinary One-Stop Breast Clinic
Voichita Suciu, Carolla El Chamieh, Ranya Soufan, et al.
American Journal of Clinical Oncology
|
November 4, 2009
DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer
Christophe M Raynaud, Juana Hernandez, Frédérique P Llorca, et al.
Anticancer Research
|
March 14, 2007
Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast
Julien Grenier, Jean-Charles Soria, Marie-Christine Mathieu, et al.
Life (Basel, Switzerland)
|
November 27, 2024
Immediate Diagnosis of Breast Carcinoma on Core Needle Biopsy Using Ex Vivo Fluorescence Confocal Microscopy: Feasibility in a One-Stop Breast Clinic Workflow
Marie-Christine Mathieu, Voichita Suciu, Marie-Laure Tanguy, et al.
The Breast Journal
|
November 11, 2018
Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations
Yoan Ditchi, Chloé Broudin, Yolla El Dakdouki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 30, 2010
Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease
Céline Bourgier, Wassim Khodari, Anne-Lise Vataire, et al.
Breast Cancer Research and Treatment
|
May 19, 2010
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients
Jean-Yves Pierga, Suzette Delaloge, Marc Espié, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
Presse Medicale (Paris, France : 1983)
|
February 16, 2010
[Elderly people, precariousness, social handicap and length of stay: pilot study at the Lariboisière-Fernand Widal Hospital Group in Paris]
Nathalie Bréchat, Magali Besnier, Thomas Vogel, et al.
Pediatric Blood & Cancer
|
May 26, 2006
Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab?
Natacha Entz-Werle, Valérie Velasco, Agnès Neuville, et al.
Cancer Investigation
|
January 19, 2019
Clinical Response to Induction Chemotherapy Predicts Outcome after Combined-Modality Therapy in Inflammatory Breast Cancer
Mauro Loi, Ariane Dunant, Sahar Ghith, et al.
Cancers
|
October 28, 2023
Real-World Diagnostic Accuracy of the On-Site Cytopathology Advance Report (OSCAR) Procedure Performed in a Multidisciplinary One-Stop Breast Clinic
Voichita Suciu, Carolla El Chamieh, Ranya Soufan, et al.
American Journal of Clinical Oncology
|
November 4, 2009
DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer
Christophe M Raynaud, Juana Hernandez, Frédérique P Llorca, et al.
Anticancer Research
|
March 14, 2007
Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast
Julien Grenier, Jean-Charles Soria, Marie-Christine Mathieu, et al.
Life (Basel, Switzerland)
|
November 27, 2024
Immediate Diagnosis of Breast Carcinoma on Core Needle Biopsy Using Ex Vivo Fluorescence Confocal Microscopy: Feasibility in a One-Stop Breast Clinic Workflow
Marie-Christine Mathieu, Voichita Suciu, Marie-Laure Tanguy, et al.
The Breast Journal
|
November 11, 2018
Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations
Yoan Ditchi, Chloé Broudin, Yolla El Dakdouki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 30, 2010
Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease
Céline Bourgier, Wassim Khodari, Anne-Lise Vataire, et al.
Breast Cancer Research and Treatment
|
May 19, 2010
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients
Jean-Yves Pierga, Suzette Delaloge, Marc Espié, et al.
Page
of 9